Starting a medical cannabis business

15 June 2019

An Expert View on a burgeoning area that should tempt life science investors and professionals to leave their prejudice behind and take a closer look, from Jeannette VanderMarel, co-founder of The Green Organic Dutchman, the world’s largest organic cannabis producer, and chief executive of 48North Cannabis.

The European medical cannabis market is set to become a $100 billion market by 2028, more than twice the revenues reported by Apple in the region last year. With a dozen cannabis companies valued on the stock market for more than $1 billion, it is a lucrative and exciting time to be investing in the industry.

"Ultimately, starting a business in medical cannabis is never simple, but with the right backing and knowledge, it’s an industry to invest in to prepare for the future"

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK